The multiplicity of drugs available and the complexities surrounding their safe and effective use make it necessary for organized health-care settings to have a sound program for maximizing rational drug use. The pharmacy and therapeutics (P&T) committee, or its equivalent, is the organizational keystone to this program.
7.
Recommendations of the committee should be presented to the medical staff or its appropriate committee for adoption or recommendation. 8. Liaison with other organizational committees concerned with drug use should be maintained. 9. Actions of the committee should be routinely communicated to the various health-care personnel involved in the care of the patient. 10. The committee should be organized and operated in a manner that ensures the objectivity and credibility of its recommendations. The committee should establish a conflict of interest policy with respect to committee recommendations and actions. 11. In formulating drug use policies for the organization, the committee should be attentive to the content and changes in pertinent guidelines and policies of professional organizations and standards-setting bodies such as the American Society of Hospital Pharmacists, the American Hospital Association, medical and nursing associations, the Joint Commission on Accreditation of Healthcare Organizations, governmental agencies, and others as appropriate.
Functions and Scope
The basic organization of each health-care setting and its medical staff may influence the specific functions and scope of the P&T committee. The following list of committee functions is offered as a guide:
1.
To serve in an evaluative, educational, and advisory capacity to the medical staff and organizational administration in all matters pertaining to the use of drugs (including investigational drugs).
2.
To develop a formulary of drugs accepted for use in the organization and provide for its constant revision. The selection of items to be included in the formulary should be based on objective evaluation of their relative therapeutic merits, safety, and cost. The committee should minimize duplication of the same basic drug type, drug entity, or drug product. 
3.
To establish programs and procedures that help ensure safe and effective drug therapy.
4.
To establish programs and procedures that help ensure cost-effective drug therapy.
5.
To establish or plan suitable educational programs for the organization's professional staff on matters related to drug use.
6.
To participate in quality-assurance activities related to distribution, administration, and use of medications.
7.
To monitor and evaluate adverse drug (including, but not limited to, biologics and vaccines) reactions in the health-care setting and to make appropriate recommendations to prevent their occurrence.
8.
To initiate or direct (or both) drug use evaluation programs and studies, review the results of such activities, and make appropriate recommendations to optimize drug use.
9.
To advise the pharmacy department in the implementation of effective drug distribution and control procedures. 10. To disseminate information on its actions and approved recommendations to all organizational health-care staff. 
